SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Marksans Pharma - Quaterly Results

11 Feb 2022 Evaluate
Revenue showed a marginal decline at Rs. 1659.37 millions. For the quarter ended December 2021, as compared to corresponding quarter of last year.Net profit declined -10.46% to Rs. 260.57 millions from Rs. 291.02 millions.The company reported a degrowth in operating Profit to 398.85 millions from 411.23 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 1659.37 1684.55 -1.49 4820.11 4619.66 4.34 5995.48 4334.15 38.33
Other Income 120.65 62.41 93.32 346.03 192.47 79.78 311.56 1.73 17909.25
PBIDT 398.85 411.23 -3.01 1214.49 1061.79 14.38 1448.68 716.63 102.15
Interest 6.85 10.98 -37.61 25.17 32.07 -21.52 53.45 72.92 -26.70
PBDT 392.00 400.25 -2.06 1189.32 1029.72 15.50 1395.23 643.71 116.75
Depreciation 45.21 40.34 12.07 130.54 110.48 18.16 151.93 116.44 30.48
PBT 346.79 359.91 -3.65 1058.78 919.24 15.18 1243.30 527.27 135.80
TAX 86.22 68.89 25.16 233.18 172.32 35.32 259.49 148.24 75.05
Deferred Tax 1.22 -10.10 -112.08 16.30 -32.97 -149.44 -22.39 36.77 -160.89
PAT 260.57 291.02 -10.46 825.60 746.92 10.53 983.81 379.03 159.56
Equity 409.31 409.31 0.00 409.31 409.31 0.00 409.31 409.31 0.00
PBIDTM(%) 24.04 24.41 -1.54 25.20 22.98 9.62 24.16 16.53 46.14

Marksans Pharma Share Price

176.85 -2.70 (-1.50%)
20-Apr-2026 10:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1674.25
Dr. Reddys Lab 1235.85
Cipla 1236.25
Zydus Lifesciences 941.20
Lupin 2336.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×